PROTECTIVE EFFECT OF L-CARNITINE AND BAKER YEAST SACCHAROMYCES CEREVISIAE AGAINST HEPATIC TOXICITY INDUCED BY VALPROATE AS ANTIEPILEPTIC DRUG IN RATS
Keywords:
Sodium valproate, Baker yeast (Saccharomyces cerevisiae), L-carnitine, Oxidative stress, Liver functionAbstract
Objective: The aim of this work was to investigate the protective role of L-carnitine and baker yeast (Saccharomyces cerevisiae) against the effect of sodium valproate (VPA) induced toxicity and oxidative stress in the liver.
Methods: Chronic administration of sodium valproate was studied by oral administration of VPA for six months. The protective effect was conducted by an administration of L-carnitine or/and baker yeast for one month before chronic administration of VPA. Some biochemical parameters, lipid profile, oxidative stress and histopathological studies were analyzed.
Results: Chronic administration of VPA for six months caused a significant increase in serum amino transferases (AST, ALT), alkaline phosphatase (ALP), bilirubin, total lipids, total cholesterol, low density lipoprotein (LDL) as well as oxidative stress; malodialdehyde (MDA) and nitric oxide. While decreased total protein, albumin, and globulin in addition to glutathione peroxidase and superoxide dismutase (SOD). The administration of L-carnitine and baker yeast cause significant decreases in the activities of AST, ALT, bilirubin, lipid peroxidation, LDL level and MDA levels and return the levels of total protein, albumin, globulin, glutathione peroxidase and SOD to the normal levels. Histopathological results revealed improvement of the liver structure.
Conclusion: L-carnitine and baker yeast (Saccharomyces cerevisiae) offer protection to the liver by preserving the structural integrity of hepatocellular membrane against sodium valproate induced hepatotoxicity and oxidative stress.
Â
Downloads
References
Hussein RR, Soliman RH, Abdelhaleem Ali AM, Tawfeik MH, Abdelrahim ME. Effect of antiepileptic drugs on liver enzymes. BJBAS 2013;2:14-9.
Elwakkad AS, El ElShamy KA, Sibaii H. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats. Epilepsy Res 2008;80:47-56.
Björnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand 2008;118:281-90.
Tolou-Ghamari Z, Palizban AA. Review of sodium valproate clinical and biochemical properties. Zahedan J Res Med Sci 2015;29-34.
Defoort EN, Kim PM, Winn LM. Valproic acid increases conservative homologous recombination frequency and reactive oxygen species formation: a potential mechanism for valproic acid-induced neural tube defects. Mol Pharmacol 2006;69:1304-10.
Khan SK, Tasleem S, Ismail N, Khan P, Shakoor KA. Prevention of hepatotoxicity of valproic acid with concomitant supplement of carnitine: an experimental study in albino rats. GJMS 2013;11:227-9.
Saleh D, Ismail MA, Ibrahim AM. Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. Pak J Biol Sci 2012;15:68-77.
Ochs-Balcom H, Grant B, Muti P, Sempos C, Freudenheim J, Browne R, et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 2006;60:991-9.
Yiiksel A, Cengiz M, Seven M, Ulutin T. Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. J Basic Clin Physiol Pharmacol 2000;11:73-81.
Tong V, Teng XW, Chang TK, Abbott FS. Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes. Toxicol Sci 2005;86:436-43.
Khan SKZ, Khan SA, Khan AU. Protective role of carnitine against the toxic effects of valproic acid on the skeletal muscles in albino rats. J Med Sci 2014;22:43-5.
Bryant AE, Dreifuss FE. Valproic acid hepatic fatalities. III. US experience since 1986. Neurol 1996;46:465-9.
Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: Carnitine in the treatment of valproic acid-induced toxicity–what is the evidence? Critical Care 2005;9:431.
Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 2007;64:2090-103.
Abdalla OA, EL-Boshy ME, Hamid FMA, Ali NM. Clinicopathological studies of dietary supplementation of Saccharomyces cerevisiae in calves. J Am Sci 2013;9(9):298-306.
Onifade A, Al-Sane N, Al-Musallam A, Al-Zarban S. A review: potentials for biotechnological applications of keratin-degrading microorganisms and their enzymes for nutritional improvement of feathers and other keratins as livestock feed resources. Bioresour Technol 1998;66:1-11.
Beghi E, Bizzi A, Codegoni AM, Trevisan D, Torri W. Valproate, carnitine metabolism, and biochemical indicators of liver function. Epilepsia 1990;31:346-52.
Bogye G, Alfthan G, Machay T. Randomized clinical trial of enteral yeast-selenium supplementation in preterm infants. Biofactors 1998;8:139-42.
Schemer S. The blood morphology of laboratory animals, (Davis–FA rd Company, Pheladephia, USA; 1967. p. 42.
Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63.
Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cantley L, et al. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 1987;50:1021-9.
Tietz PS, Holman RT, Miller LJ, LaRusso NF. Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains. Biochem 1995;34:15436-43.
Zöllner N, Kirsch K. Colorimetric method for determination of total lipids. Fur Gesampte Exp Med 1962;135:545.
Stein Y, Shapiro B. Uptake and metabolism of triglycerides by the rat liver. J Lipid Res 1960;1:326-31.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
Nishikimi M, Appaji Rao N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972;46:849-54.
Mayer AG. The tortugas, florida, as a station for research in biology. Sci (New York, NY) 1903;17:190.
Mazhar F, Shamim S, Mahmood malhi S. Drug utilization evaluation of antiepileptics in three selected multidisciplinary teaching hospitals of pakistan. Int J Pharm Pharm Sci 2014;6:59-66.
Arroyo S, De la Morena A. Life-threatening adverse events of antiepileptic drugs. Epilepsy Res 2001;47:155-74.
Al-Rouby NM, Gawish SM. Histological study on the possible protective effect of nigella sativa oil on experimentally induced hepatotoxicity in albino rats treated with sodium valproate. Glo Adv Res J Med Med Sci 2013;2:90-9.
Sadeghi Niaraki M, Nabavizadeh F, Vaezi GH, Alizadeh AM, Nahrevanian H, Moslehi A, et al. Protective effect of ghrelin on sodium valproate-induced liver injury in rat. J Stress Physiol Biochem 2013;9:96-105.
Murakami K, Sugimoto T, Woo M, Nishida N, Muro H. Effect of Lâ€Carnitine supplementation on acute valproate intoxication. Epilepsia 1996;37:687-8.
Dönmez N, Keskin E. The effects of aflatoxin and glucomannan on some antioxidants and biochemical parameters in rabbits. Acta Vet 2008;58:307-13.
Yalçınkaya I, Guengoer T, Başalan M, Erdem E. Mannan oligosaccharides (MOS) from Saccharomyces cerevisiae in broilers: Effects on performance and blood biochemistry. Turk J Vet Anim Sci 2008;32:43-8.
Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008;582:1783-7.
Singh S, Kaur R, Chahal J, Devi P, Jain D, Singla M. Conjugation of nano and quantum materials with bovine serum albumin (BSA) to study their biological potential. J Lumin 2013;141:53-9.
Silva M, Aires C, Luis P, Ruiter J, Ijlst L, Duran M, et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherited Metab Dis 2008;31:205-16.
Emami Naini A, Moradi M, Mortazavi M, Amini Harandi A, Hadizadeh M, Shirani F, et al. Effects of oral l-carnitine supplementation on lipid profile, anemia, and quality of life in chronic renal disease patients under hemodialysis: a randomized, double-blinded, placebo-controlled trial. J Nutr Metab 2012;2012:1-6.
Yang Z-H, Zeug R, Wang Y, Li X-K, Lv Z-S, Lai B, et al. Tolerance of immobilized yeast cells in imidazolium-based ionic liquids. Food Technol Biotechnol 2009;47:62.
Sener G, Toklu HZ, Cetinel S. β-Glucan protects against chronic nicotine-induced oxidative damage in rat kidney and bladder. Environ Toxicol Pharmacol 2007;23:25-32.
Kathirvel E, Morgan K, Dinh PL, French SW, Morgan TR. combination of acetyl-l-carnitine and lipoic acid improves liver enzymes in a high fat diet mouse model of non-alcoholic fatty liver disease (nafld). in Hepatology. Wiley-blackwell 111 river st, hoboken 07030-5774, nj USA; 2012.
Udristioiu A, Iliescu RG, Cojoraru M, Udristioiu A. Alkaline phosphatase isoenzymes and leukocyte alkaline phosphatase score in patients with acute and chronic disease: a brief review. Br J Med Med Res 2014;4:340-50.
Augustyniak A, Skrzydlewska E. L-Carnitine in the lipid and protein protection against ethanol-induced oxidative stress. Alcohol 2009;43:217-23.
Ghadir MR, Riahin AA, Havaspour A, Nooranipour M, Habibinejad AA. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepatitis Monthly 2010;10:285.
Deb Mandal M, Mandal S. Coconut Cocos nucifera L. Arecaceae). In: health promotion and disease prevention. Asian Pac J Trop Med 2011;4:241-7.
Verrotti A, Basciani F, Trotta D, Pomilio M, Morgese G, Chiarelli F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res 2002;48:71-5.
Sonmez FM, Demir E, Orem A, Yildirmis S, Orhan F, Aslan A, et al. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J Child Neurol 2006;21:70-4.
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatol 2007;45:1366-74.
Akande AA, Akinyinka AO. Serum malondialdehyde levels during menstral cycle. Afr J Biotechnol 2005;4.
Martinez-Ballesteros C, Pita-Calandre E, Sanchez-Gonzalez Y, Rodriguez-Lopez C, Agil A.[Lipid peroxidation in adult epileptic patients treated with valproic acid]. Rev Neurol 2003;38:101-6.
Schulpis KH, Lazaropoulou C, Regoutas S, Karikas GA, Margeli A, Tsakiris S, et al. Valproic acid monotherapy induces DNA oxidative damage. Toxicol 2006;217:228-32.
Henshall DC, Simon RP. Epilepsy and apoptosis pathways. J Cereb Blood Flow Metab 2005;25:1557-72.
ALshafei MM, Kassem SS, Kader MMA. Effect of long term treatment with antiepileptic drugs on oxidant status, Zinc and magnesium in epileptic patients. World Appl Sci J 2013;28 316-23.
Martinc B, Grabnar I, Vovk T. The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Curr Neuropharmacol 2012;10:328.
Hamed SA, Abdellah MM, El-Melegy N. Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 2004;96:465-73.
Azam F, VV Prasad M, Thangavel N. Targeting oxidative stress component in the therapeutics of epilepsy. Curr Top Med Chem 2012;12:994-1007.
Shaat EA, Ali SM, Madkour S. Effect of l-carnitine and deferoxamine on hepatotoxicity, erythrocyte ergothioneine and testicular testosterone synthesis in sodium valproate-treated rats. Bull Alex Fac Med 2006;42:1.
Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9.
Peker E, Oktar S, Arı M, Kozan R, Doğan M, Çağan E, et al. Nitric oxide, lipid peroxidation, and antioxidant enzyme levels in epileptic children using valproic acid. Brain Res 2009;1297:194-7.
Karabiber H, Yakinci C, Durmaz Y, Temel I, Mehmet N. Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain Dev 2004;26:15-8.
Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76.
James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Disposition 2003;31:1499-506.
Thaakur S, Chandravadana Y. Influence of spirulina fusiformis on the sodium Valproate induced hepatotoxicity and oxidative Stress. Pharmacologyonline 2008.
Gülçin Ä°, ElmastaÅŸ M, Aboulâ€Enein HY. Determination of antioxidant and radical scavenging activity of Basil (Ocimum basilicum L. Family Lamiaceae) assayed by different methodologies. Phytother Res 2007;21:354-61.
Temple MD, Perrone GG, Dawes IW. Complex cellular responses to reactive oxygen species. Trends Cell Biol 2005;15:319-26